Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 43 Breast Neoplasms 31 Prostatic Neoplasms 27 Colorectal Neoplasms 26 Lung Neoplasms 17 Hematopoietic and Lymphatic System Neoplasm 12 Ovarian Neoplasms 11 Hematologic Neoplasms 11 Uterine Cervical Neoplasms 7 Multiple Myeloma 7 Lymphoma 7 Leukemia 7 Head and Neck Neoplasms 6 Endometrial Neoplasms 6 Depression 6 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Pancreatic Neoplasms 5 Leukemia, Myeloid, Acute 5 Urinary Bladder Neoplasms 4 Rectal Neoplasms 4 Mouth Neoplasms 4 Motor Activity 4 Melanoma 4 Hematopoietic and Lymphoid System Neoplasm 4 Gastrointestinal Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Anxiety Disorders 4 Advanced Cancer 4 Triple Negative Breast Neoplasms 3 Stomach Neoplasms 3

Interventions

Cyclophosphamide 53 Etoposide 33 Temozolomide 28 Irinotecan 28 Melphalan 25 Filgrastim 25 Topotecan 24 Carboplatin 24 3-Iodobenzylguanidine 23 Isotretinoin 20 Granulocyte Colony-Stimulating Factor 17 sargramostim 16 humanized 3F8 anti-GD2 monoclonal antibody 16 dinutuximab 16 Granulocyte-Macrophage Colony-Stimulating Factor 16 fludarabine 15 Vincristine 15 Doxorubicin 15 Cisplatin 15 Peripheral Blood Stem Cell Transplantation 14 Interleukin-2 14 Busulfan 13 naxitamab 12 Thiotepa 12 Radiotherapy 12 aldesleukin 11 fludarabine phosphate 10 etoposide phosphate 8 Mesna 8 Ifosfamide 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Neuroblastoma × Interviews as Topic × Clear all

NCT02780128 2026-03-10

NEPENTHE

Children's Hospital of Philadelphia

Phase 1 Terminated

Neoplasms, Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡